The European Commission has signed a contract with the pharmaceutical company Gilead to secure treatment doses of Veklury, the brand name for Remdesivir. Veklury was the first medicine authorized at EU level for treatment of COVID-19.
As from early August onwards, and in order to meet immediate needs, batches of Veklury will...
European Commission Secures EU Access To Remdesivir For Treatment Of COVID-19
Eurasia Review
0 shares
1 views
You might like
Related news coverage
Greece: Call To Investigate Pushbacks, Collective Expulsions
Eurasia Review
Greek law enforcement officers have summarily returned asylum seekers and migrants at the land and sea borders with Turkey during..
-
Experts Give Weak Recommendation For Remdesivir In Severe COVID-19 Cases
Eurasia Review
-
NA Proactive news snapshot: TruTrace Technologies, ElectraMeccanica, WeedMD, Medicago, LexaGene, Orgenesis UPDATE ...
Proactive Investors
-
NA Proactive news snapshot: ElectraMeccanica, WeedMD, Medicago, LexaGene, Orgenesis UPDATE ...
Proactive Investors
-
NA Proactive news snapshot: BevCanna Enterprises, VolitionRx, Hillcrest Petroleum, Orgenesis …
Proactive Investors
Advertisement
More coverage
Beijing’s Soft Diplomacy In West Asia In Times Of COVID-19 – Analysis
Eurasia Review
By Nagapushpa Devendra*
The coronavirus disease (COVID-19) that emerged from Wuhan in China in December 2019 has..
-
NA Proactive news snapshot: Ipsidy, Avalon GloboCare, BioSig Technologies, Co-Diagnostics, Black Iron, Thunderbird Entertainment UPDATE …
Proactive Investors
-
Gilead Sciences' COVID-19 Treatment Earns Conditional Approval in Europe
Motley Fool
-
EU Approves Gilead's Remdesivir To Treat COVID-19
RTTNews
-
EU approves remdesivir for COVID-19 treatment
SBS